$59.850
-1.945 (-3.25%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CGON por análisis de gráficos similares
Alphio's CGON stock price prediction model matches the current CG Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $59.88 (+0.05%). The 1-week path is $59.91 (+0.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de CG Oncology Inc?
CG Oncology Inc is not a good buy right now due to significant financial losses and negative technical indicators. The current price is $59.85, with an RSI of 18.48 indicating oversold conditions. The company reported a net income loss of $79,056,000 in Q2 2026, which raises concerns about its profitability and sustainability. The main risk is the ongoing negative earnings trend, with EPS reported at -$0.90, which reflects the company's struggle to achieve profitability amidst rising R&D expenses.
CGON cerró en $59.85 el Friday, tras bajar -3.25%
CG Oncology Inc (CGON) last closed at $59.85, losing -3.25%. These facts feed the 1-day and 1-week CGON price prediction above.
Factores de la previsión
Los factores de la previsión de CG Oncology Inc (CGON) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CGON, ordenadas por similitud.
Análisis de estacionalidad de CGON
Historically the probability of a positive October return for CGON is 65.52%. September offers the highest probability of a positive month at 79.03%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.